BioMarin Reports First Quarter 2026 Financial and Operating Results
Go back to BioMarin Reports First Quarter 2026 Financial and Operating Results| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 62.07 +1.80 (2.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.27 | 52 Week High | $108.96 | |||
| Open | $61.00 | 52 Week Low | $62.12 | |||
| Day High | $63.05 | P/E | N/A | |||
| Day Low | $60.93 | EPS | $-1.27 | |||
| Volume | 1,942,199 | |||||
